Viewing nowCombinationTelmisartan/Amlodipine 40/5 mg
Telmisartan 40mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
NBK Pharmaceutical Co., Ltd.

MFDS item code 202002376 · Approved 2020.04.05 · Insurance code 054800900
Treatment of essential hypertension not controlled with monotherapy
This medicine is used in patients with essential hypertension whose blood pressure is not sufficiently controlled with monotherapy of telmisartan or amlodipine. Hypertension is a persistent high blood pressure condition that increases the risk of cardiovascular disease, making proper blood pressure control crucial. This medication effectively lowers blood pressure, improving heart and vascular health. It is a therapeutic agent that helps to stably manage blood pressure according to the patient's condition.
The recommended dose of this medicine is 1 tablet once daily, taken with water, regardless of meals. If possible, it is recommended to take it at the same time each day (e.g., in the morning). It is recommended to adjust the dose using the individual components (telmisartan or amlodipine) before starting this medicine. However, if blood pressure is not controlled with the individual components as follows, switching directly to this medicine may be considered. - 40/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this medicine 40/5 mg. - 40/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg. Patients taking telmisartan and amlodipine concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience (limited to this medicine 40/5 mg). ○ Patients with renal impairment: No dosage adjustment is necessary in patients with mild or moderate renal impairment. In patients with severe renal impairment, however, it is recommended to initiate treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 mg in patients with mild or moderate hepatic impairment. ◦ Older adults: The usual amlodipine regimen is recommended for older adults, but caution should be exercised when increasing the dose (see section ‘3. Patients Requiring Caution’). In older adults aged 75 years or older, amlodipine clearance is reduced; therefore, treatment should be initiated at a low dose and the dose increased gradually.
○ Children: Use of this medicine is not recommended in pediatric patients 18 years of age or younger because its safety and efficacy have not been established.
This drug can cause serious health issues to the fetus or newborn when taken during pregnancy, especially in the second and third trimesters, and therefore should not be taken by women who are pregnant or may become pregnant. This drug should not be administered to patients with specific diseases, such as those with severe liver or heart problems, severe hypotension, and certain genetic disorders. Patients with primary aldosteronism, heart valve disease, liver dysfunction, gastrointestinal disorders, kidney disease, the elderly, and others need special caution when using this drug. Common side effects such as dizziness or swelling may occur while taking this drug, and serious side effects can occur rarely; therefore, if any unusual symptoms arise, consult a healthcare professional immediately. This drug should not be used during pregnancy, and if pregnancy is confirmed, treatment should be discontinued as soon as possible, and alternative therapy should be sought. Hypotension may occur, so patients who are deficient in fluid or salt should adjust their condition before taking this drug and monitor their status carefully during treatment. Since there is a risk of elevated potassium levels in the blood, caution is needed if supplementing with potassium or taking medications containing potassium. Patients with decreased kidney function should have their kidney function and serum electrolyte levels monitored regularly while taking this drug. Patients with heart disease should be cautious as this drug may worsen symptoms of myocardial infarction or angina. This drug may cause drowsiness or dizziness, so extra care should be taken while driving or operating hazardous machinery during treatment. This drug may interact with other medications, so if you are taking any other medications, be sure to inform your healthcare provider. The elderly may be more sensitive to this drug, so it is safer to start at a lower dose and gradually increase. In cases of overdose, symptoms such as decreased blood pressure, dizziness, and abnormal heart rhythms may occur, and appropriate treatment should be sought immediately at a medical facility. This drug is not recommended for children as its safety and efficacy have not been established in this population. Store this medication away from children, and open the packaging immediately before taking.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to light, so it should be stored in a container that protects against light and kept at room temperature between 1 and 30 degrees Celsius. Therefore, it is important to avoid direct sunlight and not to store it in excessively hot or cold places.
Biconvex oval dual tablet in white and light blue color
30 tablets (10 tablets/PTP x 3)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
NBK Pharmaceutical Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
ILDONG Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.